Skip to content
Home page - Centenary Institute Centenary Institute

Primary menu

  • Research
        • Research

          The latest medical research into our most complex health challenges across biomedical AI, cancer, cardiovascular diseases, immunity, age-related, rare and infectious diseases.

          Learn more

        • Biomedical AI
        • Cancer Innovations
        • Cardiovascular Research
        • Healthy Ageing
        • Infection & Immunity
        • Rare Diseases & Gene Therapy
        • Laboratories
        • Diseases
        • Breakthroughs
        • Technologies
        • Commercialisation
  • Support us
        • Support us

          By supporting the Centenary Institute you can help improve human health through excellence in medical research.

          Learn more

        • Workplace giving
        • Host or join a fundraiser
        • Gift in your will
        • Donate in memory
        • Community and research
  • Careers & students
        • Careers & Students

          Postdoctoral and postgraduate students can work alongside world-leading medical researchers within state-of-the-art research facilities.

        • Careers
        • Study opportunities
  • Health hub
        • Health hub

          A range of practical information to assist in the possible preventions to disease through evidence-based research on how the body works.

          Learn more

        • Ageing
        • Exercise snack program
  • News & events
        • News & Events

          Explore the latest research breakthroughs and ways you can take part in our series of digital and in-person events.

        • News
        • Statements
        • Events
        • Real stories
  • About us
        • About us

          We are world-leading independent medical research institute that drives collaboration to accelerate and translate solutions to our most complex health challenges.

          Learn more

        • Governance
        • Corporate information
        • Annual reports
        • Our researchers
        • Animals in research
        • Contact
  • Donate
    Centenary Institute > News > Aspirin could make urinary tract infections worse

Aspirin could make urinary tract infections worse

Date time 15 November, 2021
News Type News type Media release
New research by the Centenary Institute suggests that commonly prescribed anticoagulants – medicines, such as aspirin, that help prevent blood clots – may make urinary tract infections (UTIs) more severe.

One of the most common infections worldwide, UTIs are not normally serious or life threatening but in rare cases can progress into sepsis, also known as septicaemia.

In older people the risk of developing severe UTIs often overlaps with conditions that require anticoagulant treatment.

Researchers found that in zebrafish, the commonly prescribed anticoagulant medications – specifically aspirin and warfarin – increased UTI severity.

“We commonly use zebrafish in medical research to better understand diseases in order to find cures,” said Dr Stefan Oehlers, Head of the Centenary Institute’s Immune-Vascular Interactions Laboratory and study senior author.

“Zebrafish share 70 percent of the same genes as people and 84 percent of human genes known to be associated with human diseases have a zebrafish counterpart. This makes them perfect for study.”

Dr Oehlers said that UTI-associated sepsis is most often caused by uropathogenic Escherichia coli (UPEC), a bacterium that first infects the urinary system.

“We used the zebrafish to model the sepsis phase of UPEC infection,” said Dr Oehlers.

“Using this model we demonstrated that commonly used anticoagulant medicines reduced zebrafish survival and increased UPEC bacteria burden.”

The researchers believe that the administration of the anticoagulant medications prevented natural clotting that would have helped to contain bacteria in the blood.

The research was published in the journal Microbiological Research.

Publication: Common anti-haemostatic medications increase the severity of systemic infection by uropathogenic Escherichia coli.

Themes

  • Inflammation

    Inflammation

Media enquires

For all media and interview enquiries, please contact Tony Crawshaw

Phone number Phone Number +61 402 770 403

Email Email t.crawshaw@centenary.org.au

Media Release

Common anti-haemostatic medications increase the severity of systemic infection by uropathogenic Escherichia coli.

Download

Recent Stories

  • Centenary researchers share insights at ageing conference

    Centenary Institute researchers played a prominent role at the Australian Biology of Ageing Conference 2025 this week, contributing new scientific insights on how Australians can live healthier lives as they age.
    News Type: Research News
    Date 20 Nov 2025
  • New gene discoveries improve diagnosis of inherited heart disease

    Centenary Institute researchers have uncovered new genetic causes of inherited heart conditions, providing families with vital answers to guide treatment and prevention.
    News Type: Media release
    Date 13 Nov 2025
  • Centenary exhibits at Government House

    The Centenary Institute has shared the beauty of science with the wider community through its When Art Meets Science exhibition, featured at Government House Sydney as a part of Sydney Open Day.
    News Type: Community
    Date 04 Nov 2025
  • Grant awarded to study gut-liver communication

    Associate Professor Patrick Bertolino, Head of the Centre for Infection & Immunity at the Centenary Institute, and Associate Professor David Bowen from the same centre, have been awarded a 2025 Gastroenterological Society of Australia (GESA) Project Grant. The $50,000 grant will support their study ‘Decoding Microbiome–Liver Communication via Portal Tracts.’
    News Type: Research News
    Date 22 Oct 2025

Subscribe to receive news on
research updates and free events

Newsletter

The Centenary Institute is a world-leading independent Medical Research Institute.

We acknowledge the Gadigal of the Eora Nation, the traditional custodians of the Country on which the Centenary Institute stands.

About

  • About us
  • Governance
  • Corporate information

Research

  • Our researchers
  • News

Careers & studies

  • Career opportunities
  • Student opportunities
  • Life at Centenary

Links

  • Contact
  • Privacy statement
  • Staff Intranet

Contact us

Building 93, Royal Prince Alfred Hospital
Missenden Rd
Camperdown NSW 2050 Australia
Telephone +61 2 9565 6100
Fax +61 2 9565 6101

Contact Privacy

Centenary Institute ABN 22 654 201 090 (DGR 1) • Centenary Institute Medical Research Foundation ABN 85 778 244 012 (DGR 2)
© 2017 Centenary Institute of Cancer Medicine and Cell Biology.

  • Linkedin
  • Facebook
  • Twitter
  • Youtube
  • Instagram